查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1802749

双焦人工水晶体市场（按技术、材料、视觉性能、通路和应用）—2025-2030 年全球预测

Bifocal Intraocular Lens Market by Technology, Material, Visual Performance, Distribution Channel, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

双焦人工水晶体市场预计将在 2024 年达到 16.3 亿美元，在 2025 年将成长至 17.3 亿美元，在 2030 年将达到 23.2 亿美元，复合年增长率为 6.05%。

主要市场统计数据
基准年2024年 16.3亿美元
预计2025年 17.3亿美元
预计2030年 23.2亿美元
复合年增长率（%） 6.05%

简要说明影响双焦点人工水晶体临床应用、技术差异化和以患者为中心的视觉效果的策略因素

双焦人工水晶体市场正处于快速临床创新与患者对术后视觉效果期望不断变化的交会点。随着外科医生和设备开发人员越来越重视跨多个焦平面的功能性视觉，双焦晶状体技术已从小众的实验设计发展成为临床认可的解决老花眼和白内障相关视力障碍的解决方案。本报告综合分析了技术差异、材料科学的进步、分销动态以及影响该领域应用路径的监管考量，为竞争格局和临床前景提供了简明的指导。

光学、生物材料、临床路径和付款人期望的进步如何融合，重新定义双焦点人工水晶体的采用和竞争优势

由于光学工程、材料科学和临床实践的融合，双焦人工水晶体领域正在发生重大变化。光学设计师正在改进衍射轮廓和屈光形状，以改善中距视力，同时减少诸如晕光和对比敏感度下降等常见缺陷。同时，由于生物相容性、耐光性和涂层性能的差异，亲水性和疏水性丙烯酸和硅树脂配方的进步正在影响外科医生的偏好。

评估 2025 年美国关税调整如何重塑渐进式人工水晶体生态系统的供应链弹性、筹资策略和贸易流

2025年美国新关税的实施，正在为渐进式人工水晶体价值链带来显着压力，影响采购决策、定价策略和库存规划。依赖跨境零件供应和美国境外最终组装的製造商正在评估近岸外包和双重采购方案，以降低客製化相关的成本波动。这些调整促使采购团队重新评估供应商合同，以纳入特殊光学和聚合物零件的更长前置作业时间，从而影响生产计划和客户回应时间。

细分领域的分析揭示了推动临床选择和商业化策略的技术、材料、性能、分销和应用动态

基于细分市场的洞察阐明了临床需求和机会的交汇点，突显了技术、材料、视觉性能、分销管道和应用等方面的可行重点。基于架构，衍射和屈光镜片之间的市场差异影响光学权衡；在屈光方法中，同心和分段架构可提供不同的焦深和患者特定定製配置。基于材料，亲水性丙烯酸酯、疏水性丙烯酸酯和硅酮之间的性能差异为器械选择提供了参考，每种器械都需要独特的物料输送特性、囊体相互作用和长期清晰度考虑。基于视觉性能，临床医生和患者优先考虑对比敏感度、焦深、光晕和眩光等结果，这些终点推动着术前咨询和产品选择演算法。基于销售管道，采用由营运模式（门诊手术中心、医院和眼科诊所）驱动，这些模式在采购週期、报销结构和手术全期服务预期方面各不相同。在应用领域，白内障手术和屈光晶状体置换术的独特临床路径定义了产品需求，而白内障手术又进一步细分为囊外白内障摘除术和乳化术，这给术中操作和植入带来了不同的限制。结合这些细分领域，可以发现一些尚未满足的临床需求，在这些领域，渐进式创新和有针对性的商业项目可能会为製造商、付款方和供应商网路带来显着的益处。

美洲、中东和非洲以及亚太地区的区域动态和战略影响将决定招募、采购和商业化的成功

区域动态正在塑造渐进式人工水晶体的临床实务模式和商业性路线，从而在每个区域形成独特的策略要务。在美洲，成熟的报销框架、大量的手术量以及对患者报告结果的日益重视，正在加速对先进光学技术和循证差异化的需求。在欧洲、中东和非洲，不同的医疗保健融资、监管时间表和医院采购惯例正在创造不同的采用曲线，更倾向于本地化的临床数据和有针对性的付款人参与，而不是广泛的全球索赔。在亚太地区，快速扩张的手术能力、不断增长的中阶屈光矫正需求以及集中的製造能力，正在为规模化、本地合作伙伴关係以及根据区域解剖结构和生活方式进行迭代产品调整创造机会。

产品创新、材料领先、临床证据和服务主导的商业化如何改变渐进式人工水晶体製造商的竞争定位

渐进式人工水晶体领域的竞争优势日益依赖独特的光学特性、材料科学的领先地位、临床证据的累积以及综合的商业支持。主要企业正在加大研发投入，以改善衍射阶跃轮廓和屈光过渡区，平衡近视和中视，同时最大限度地减少光致发光现象。同时，针对光致发光、涂层生物相容性和植入过程中物料输送的技术创新，正成为影响外科医师偏好和长期治疗效果的关键因素。

製造商和供应商应采取实际的策略步骤，加强证据、保障供应链安全，并调整商业化模式以实现永续采用

产业领导者应优先考虑一系列切实可行的行动，将市场讯号转化为可持续的竞争优势。首先，投资于比较临床证据，重点关注对比敏感度、景深和患者报告的视力障碍等功能性结果，以证实差异化索赔并支持付款人对话。其次，优化供应链架构，考虑近岸外包、关键光学和聚合物组件的双重采购以及灵活的库存管理，以减少贸易波动的影响并确保手术的连续性。第三，制定针对门诊手术中心、医院和眼科诊所独特需求的市场策略，提供差异化的培训、实施支援和资金筹措模式，以反映每个管道的采购计划和临床工作流程。

我们透明的调查方法结合了初步临床检验、严格的二次研究和三角测量，以提供可操作且令人信服的市场洞察。

本研究整合了主要定性资讯、二手文献综述和方法论三角检验，以确保对双焦点人工水晶体市场前景做出均衡且合理的解读。主要资讯包括对执业眼科医师、手术中心和医院的采购负责人以及器械商业化专家的结构化访谈，并辅以匿名临床医生报告的结果观察。二级资讯来源包括同行评审的临床文献、监管文件、产品说明书和行业白皮书，并进行交叉引用以检验技术声明和性能概况。

整合临床、操作和商业性的必要性，以扩大渐进式人工水晶体的采用并改善患者的治疗效果

双焦人工水晶体的累积评估表明，这是一个充满机会的微妙环境，技术改进、材料进步和循证商业化将决定其成功与否。临床团队正在寻求既能优化功能性视力，又不损害对比度或避免过度光感的解决方案，而能够显着改善这些指标的製造商将获得广泛的市场。同时，贸易动态和医疗保健体系的差异性对传统的分销模式构成了挑战，因此，供应链的韧性和本地化定制的行销策略至关重要。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 在老花眼矫正手术中，越来越多地使用具有延长景深的双焦点人工水晶体来改善不同距离的视力。
  • 增加对先进疏水性丙烯酸双焦点人工水晶体材料的投资，以降低后囊膜混浊率
  • 越来越多的散光双焦点人工水晶体出现，以满足散光和老花眼患者的需求
  • 全球人口老化和白内障手术数量增加加速新型EDOF双焦人工水晶体的监管核准
  • 非球面衍射双焦人工水晶体设计的技术进步可提高低照度条件下的对比敏感度
  • 眼科设备公司与研究机构建立策略伙伴关係，共同开发下一代多焦点人工水晶体平台
  • 竞争性的价格压力正在推动製造商在不影响品质的情况下创新具有成本效益的双焦点 IOL 解决方案。
  • 扩大远距眼科服务，以促进双焦人工水晶体（IOL）患者的远端术后监测和追踪。
  • 越来越多的患者偏好使用优质双焦人工水晶体，无需佩戴眼镜来覆盖多个视区

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第八章双焦人工水晶体市场（按技术）

  • 绕射
  • 屈光
    • 同心圆
    • 按行业

第九章双焦人工水晶体市场（依材料）

  • 亲水性丙烯酸
  • 疏水性丙烯酸
  • 硅酮

第十章双焦人工水晶体市场（依视觉表现）

  • 对比敏感度
  • 焦深
  • 光晕和眩光

第 11 章双焦点人工水晶体市场（依通路）

  • 门诊手术中心
  • 医院
  • 眼科诊所

第 12 章双焦点人工水晶体市场（依应用）

  • 白内障手术
    • 白内障囊外摘除术
    • 超音波
  • 屈光水晶体置换

第十三章美洲双焦人工水晶体市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 14 章欧洲、中东和非洲双焦点人工水晶体市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15. 亚太地区双焦人工水晶体市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Alcon Inc.
    • Johnson & Johnson Vision Care, Inc.
    • Bausch Health Companies Inc.
    • Biotech Healthcare Group
    • Care Group Global Solutions
    • Carl Zeiss Meditec AG
    • EyeKon Medical, Inc.
    • Hanita Lenses RCA Ltd.
    • Hoya Corporation
    • HumanOptics AG
    • Lenstec, Inc.
    • Ophtec BV
    • Rayner Intraocular Lenses Limited
    • Santen Pharmaceutical Co., Ltd.
    • STAAR Surgical Company

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

Product Code: MRR-9A6A6F297783

The Bifocal Intraocular Lens Market was valued at USD 1.63 billion in 2024 and is projected to grow to USD 1.73 billion in 2025, with a CAGR of 6.05%, reaching USD 2.32 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.63 billion
Estimated Year [2025] USD 1.73 billion
Forecast Year [2030] USD 2.32 billion
CAGR (%) 6.05%

A concise orientation to bifocal intraocular lens clinical adoption, technological distinctions, and the strategic forces reshaping patient-centric visual outcomes

The bifocal intraocular lens market sits at the confluence of rapid clinical innovation and shifting patient expectations for postoperative visual outcomes. As surgeons and device developers increasingly prioritize functional vision across multiple focal planes, bifocal lens technologies have matured from niche experimental designs into clinically accepted solutions that address presbyopia and cataract-related visual impairment. This report delivers a concise orientation to the competitive and clinical environment by synthesizing technological distinctions, material science advances, distribution dynamics, and regulatory considerations that shape adoption pathways.

Within clinical practice, bifocal intraocular lenses are being integrated into established surgical workflows while presenting new preoperative counseling and postoperative management imperatives. Ophthalmic teams must reconcile optical trade-offs such as contrast sensitivity and dysphotopsia with the tangible benefits of reduced spectacle dependence for activities at near and intermediate distances. Meanwhile, device developers continue to refine diffractive and refractive approaches to minimize photic phenomena and broaden the envelope of acceptable visual performance across diverse patient anatomies. This introduction frames the subsequent sections by clarifying the core dimensions that influence technology selection, clinical outcomes, and strategic positioning in the global landscape.

How converging advances in optics, biomaterials, clinical pathways, and payer expectations are redefining adoption and competitive advantage in bifocal intraocular lenses

The landscape of bifocal intraocular lenses is undergoing transformative shifts driven by converging forces in optics engineering, materials science, and clinical practice. Optical designers are refining diffractive profiles and refractive geometries to improve intermediate vision while attenuating common trade-offs such as halos and reduced contrast sensitivity. Concurrently, advances in hydrophilic and hydrophobic acrylic formulations and silicone options are influencing surgeon preferences through differences in biocompatibility, glistening resistance, and capsular behavior.

At the same time, surgical pathways and care settings are evolving: ambulatory surgical centers and specialized ophthalmic clinics are expanding their capabilities to deliver higher volumes of refractive cataract procedures, impacting device selection and pricing negotiations. Regulatory environments and payer perspectives are prompting manufacturers to demonstrate clearer clinical value through robust comparative outcomes and patient-reported metrics. Taken together, these shifts create both opportunities and constraints for stakeholders seeking to scale bifocal lens adoption while preserving clinical quality and patient satisfaction. The net effect is a market that rewards technical differentiation supported by strong clinical evidence and pragmatic commercialization strategies.

Assessment of how 2025 U.S. tariff adjustments are reshaping supply chain resilience, sourcing strategies, and commercial dynamics across the bifocal intraocular lens ecosystem

The introduction of new tariff measures in the United States during 2025 has introduced measurable pressures across the bifocal intraocular lens value chain, affecting sourcing decisions, pricing strategies, and inventory planning. Manufacturers that rely on cross-border component supply or final assembly outside the U.S. are evaluating nearshoring and dual-sourcing options to mitigate customs-related cost volatility. These adjustments have prompted procurement teams to reassess supplier contracts and to factor in longer lead times for specialty optics and polymer components, thereby influencing production scheduling and customer fulfillment timelines.

In parallel, distributors and institutional buyers are responding to cost pass-through considerations by renegotiating commercial terms and seeking value-added services to preserve margins without eroding clinical quality. Clinicians and hospital administrators are increasingly attentive to total cost of care impacts, including device longevity, complication rates, and patient satisfaction metrics that support reimbursement conversations. Moreover, some manufacturers are accelerating regulatory and quality system investments in domestic facilities to reduce tariff exposure and to strengthen supply chain resilience. Taken together, these adaptations underscore the importance of proactive scenario planning and flexible procurement strategies to navigate the evolving trade environment while maintaining continuity of clinical supply and patient access.

Segment-level analysis revealing technological, material, performance, distribution, and application dynamics that drive clinical choice and commercialization strategies

Segmentation-driven insight clarifies where clinical needs and commercial opportunity intersect and highlights actionable focal points across technology, material, visual performance, distribution channels, and applications. Based on Technology, market distinctions between Diffractive and Refractive designs influence optical trade-offs; within Refractive approaches, Concentric and Sectorial architectures provide differing profiles for depth of focus and patient-specific customization. Based on Material, device selection reflects performance differences between Hydrophilic Acrylic, Hydrophobic Acrylic, and Silicone, each presenting unique handling characteristics, capsular interactions, and long-term clarity considerations. Based on Visual Performance, clinicians and patients prioritize outcomes across Contrast Sensitivity, Depth of Focus, and Halos & Glare, and these endpoints increasingly drive preoperative counseling and product selection algorithms. Based on Distribution Channel, adoption is mediated by the operational models of Ambulatory Surgical Centers, Hospitals, and Ophthalmic Clinics, which vary in procurement cycles, reimbursement mix, and perioperative service expectations. Based on Application, distinct clinical pathways for Cataract Surgery and Refractive Lens Exchange define product requirements, with Cataract Surgery further differentiated between Extracapsular Cataract Extraction and Phacoemulsification techniques that impose discrete intraoperative handling and implantation constraints. Integrating these segmentation lenses reveals pockets of unmet clinical need and informs where incremental innovation or targeted commercial programs can yield disproportionate returns for manufacturers, payers, and provider networks.

Regional dynamics and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption, procurement, and commercialization success

Regional dynamics shape both clinical practice patterns and commercial routes for bifocal intraocular lenses, producing distinct strategic imperatives in each geography. In the Americas, mature reimbursement frameworks, high procedural volumes, and a growing emphasis on patient-reported outcomes accelerate demand for advanced optics and evidence-based differentiation, while supply chain considerations and tariff exposure influence sourcing strategies. In Europe, Middle East & Africa, heterogeneity in healthcare financing, regulatory timelines, and hospital procurement practices fosters diverse adoption curves where localized clinical data and targeted payer engagement matter more than broad global claims. In Asia-Pacific, rapid expansion of surgical capacity, rising middle-class demand for refractive outcomes, and concentrated manufacturing capabilities create opportunities for scale, local partnerships, and iterative product adaptation to regional anatomical and lifestyle considerations.

Across regions, differences in surgical technique prevalence, distribution channel dominance, and material preferences necessitate region-specific go-to-market playbooks. Manufacturers and distributors that tailor their evidence generation, training programs, and supply models to regional priorities can reduce friction in adoption and improve clinician satisfaction. Furthermore, ongoing demographic shifts and the rising prevalence of presbyopia-age cohorts across these regions underscore the need for differentiated commercial tactics that consider payer constraints, surgeon networks, and local regulatory pathways.

How product innovation, materials leadership, clinical evidence, and service-driven commercialization are reshaping competitive positioning among bifocal intraocular lens manufacturers

Competitive differentiation in the bifocal intraocular lens arena increasingly rests on the interplay between proprietary optical profiles, material science leadership, clinical evidence generation, and integrated commercial support. Leading companies are investing in R&D to refine diffractive step profiles and refractive transition zones that balance near and intermediate acuity with minimal photic phenomena. In parallel, material innovations that address glistening, capsular biocompatibility, and implantation handling have emerged as meaningful contributors to surgeon preference and long-term outcomes.

Strategic portfolios now emphasize not only stand-alone product performance but also value-added services such as surgeon training, patient education platforms, and bundled care solutions that make adoption more seamless for clinical teams. Some manufacturers pursue regional manufacturing footprints to optimize supply chain agility and tariff exposure, while others form strategic partnerships with distributors and surgical centers to accelerate clinical adoption. Intellectual property protection, clinical trial design that emphasizes patient-reported endpoints, and clear reimbursement support materials have become critical competitive levers. Ultimately, companies that align technical differentiation with pragmatic commercialization and service models will sustain momentum in increasingly discerning clinical markets.

Practical strategic steps for manufacturers and providers to strengthen evidence, secure supply chains, and tailor commercialization models for sustainable adoption

Industry leaders should prioritize a set of pragmatic actions to convert market signals into durable competitive advantage. First, invest in comparative clinical evidence that emphasizes functional outcomes such as contrast sensitivity, depth of focus, and patient-reported dysphotopsia to substantiate differentiated claims and support payer conversations. Second, optimize supply chain architecture by exploring nearshoring, dual sourcing of critical optical and polymer components, and flexible inventory management to reduce exposure to trade volatility and ensure surgical continuity. Third, tailor go-to-market strategies to the unique contours of Ambulatory Surgical Centers, Hospitals, and Ophthalmic Clinics by offering differentiated training, implementation support, and financing models that reflect each channel's procurement cadence and clinical workflows.

In addition, manufacturers should accelerate material science programs that address handling, long-term clarity, and intraoperative performance while aligning regulatory submissions with real-world evidence collection. Collaborations with surgical thought leaders and targeted regional pilots can shorten adoption cycles and build local credibility. Finally, embed patient-centric communication tools into the commercialization mix to set realistic expectations around spectacle independence and potential visual phenomena, thereby improving satisfaction scores and reducing revision rates. These actions, taken together, create a resilient and evidence-driven approach to growth that supports both clinical excellence and commercial sustainability.

A transparent methodological framework combining primary clinical interviews, rigorous secondary source validation, and triangulation to deliver actionable and defensible market insights

This research synthesizes primary qualitative inputs, secondary literature review, and methodological triangulation to ensure a balanced and defensible interpretation of the bifocal intraocular lens landscape. Primary inputs include structured interviews with practicing ophthalmic surgeons, procurement leads at surgical centers and hospitals, and device commercialization experts, complemented by anonymized clinician-reported outcome observations. Secondary sources comprise peer-reviewed clinical literature, regulatory filings, product IFUs, and industry white papers, all cross-referenced to validate technical claims and performance profiles.

Data synthesis applied a triangulation framework that reconciled clinical evidence, practitioner insights, and commercial realities, while sensitivity checks assessed consistency across surgical techniques, material preferences, and distribution channels. Quality controls included source provenance verification, conflict-of-interest screening for expert interviews, and audit trails for key analytical decisions. Limitations are acknowledged in areas where long-term comparative outcomes remain sparse, and such gaps are highlighted as priorities for future research. Overall, the methodology balances rigor with practical relevance to deliver insights that support clinical, regulatory, and commercial decision-making.

Synthesis of clinical, operational, and commercial imperatives that must be harmonized to expand adoption and improve patient outcomes with bifocal intraocular lenses

The cumulative assessment of bifocal intraocular lenses points to an environment of nuanced opportunity where technological refinement, material advances, and evidence-based commercialization jointly determine success. Clinical teams are seeking solutions that optimize functional vision without compromising contrast or inducing undue photic symptoms, and manufacturers that deliver demonstrable improvements across these metrics will find receptive markets. Simultaneously, supply chain resilience and regionally calibrated go-to-market approaches have become essential as trade dynamics and healthcare system heterogeneity challenge traditional distribution models.

To move from potential to realized adoption, stakeholders must align product development with robust clinical endpoints, train surgical teams effectively, and present clear value narratives to payers and procurement decision-makers. By prioritizing durability of outcomes, patient-centric communication, and flexible commercial arrangements, organizations can foster trust among surgeons and patients and reduce barriers to broader adoption. In sum, the path forward requires integrated strategies that combine scientific rigor, operational resilience, and pragmatic commercialization to expand access to bifocal intraocular lens solutions while maintaining clinical quality.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing adoption of extended depth of focus bifocal IOLs in presbyopia correction surgeries due to enhanced visual acuity across varying distances
  • 5.2. Rising investments in advanced hydrophobic acrylic bifocal IOL materials to reduce posterior capsule opacification rates
  • 5.3. Growing emergence of toric bifocal intraocular lenses catering to patients with concurrent astigmatism and presbyopia
  • 5.4. Regulatory approval acceleration of new EDOF bifocal IOLs driven by aging global population and rising cataract surgeries
  • 5.5. Technological advancements in aspheric diffractive bifocal intraocular lens designs improving contrast sensitivity under low light conditions
  • 5.6. Strategic partnerships between ophthalmic device companies and research institutes to develop next gen multifocal IOL platforms
  • 5.7. Competitive pricing pressures prompting manufacturers to innovate cost effective bifocal IOL solutions without compromising quality
  • 5.8. Expansion of teleophthalmology services facilitating remote post operative monitoring and follow up of bifocal IOL patients
  • 5.9. Increasing patient preference for premium bifocal intraocular lenses offering spectacle independence across multiple vision zones

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Bifocal Intraocular Lens Market, by Technology

  • 8.1. Introduction
  • 8.2. Diffractive
  • 8.3. Refractive
    • 8.3.1. Concentric
    • 8.3.2. Sectorial

9. Bifocal Intraocular Lens Market, by Material

  • 9.1. Introduction
  • 9.2. Hydrophilic Acrylic
  • 9.3. Hydrophobic Acrylic
  • 9.4. Silicone

10. Bifocal Intraocular Lens Market, by Visual Performance

  • 10.1. Introduction
  • 10.2. Contrast Sensitivity
  • 10.3. Depth of Focus
  • 10.4. Halos & Glare

11. Bifocal Intraocular Lens Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Hospitals
  • 11.4. Ophthalmic Clinics

12. Bifocal Intraocular Lens Market, by Application

  • 12.1. Introduction
  • 12.2. Cataract Surgery
    • 12.2.1. Extracapsular Cataract Extraction
    • 12.2.2. Phacoemulsification
  • 12.3. Refractive Lens Exchange

13. Americas Bifocal Intraocular Lens Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Bifocal Intraocular Lens Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Bifocal Intraocular Lens Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Alcon Inc.
    • 16.3.2. Johnson & Johnson Vision Care, Inc.
    • 16.3.3. Bausch Health Companies Inc.
    • 16.3.4. Biotech Healthcare Group
    • 16.3.5. Care Group Global Solutions
    • 16.3.6. Carl Zeiss Meditec AG
    • 16.3.7. EyeKon Medical, Inc.
    • 16.3.8. Hanita Lenses R.C.A. Ltd.
    • 16.3.9. Hoya Corporation
    • 16.3.10. HumanOptics AG
    • 16.3.11. Lenstec, Inc.
    • 16.3.12. Ophtec BV
    • 16.3.13. Rayner Intraocular Lenses Limited
    • 16.3.14. Santen Pharmaceutical Co., Ltd.
    • 16.3.15. STAAR Surgical Company

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. BIFOCAL INTRAOCULAR LENS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. BIFOCAL INTRAOCULAR LENS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. BIFOCAL INTRAOCULAR LENS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. BIFOCAL INTRAOCULAR LENS MARKET: RESEARCHAI
  • FIGURE 26. BIFOCAL INTRAOCULAR LENS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. BIFOCAL INTRAOCULAR LENS MARKET: RESEARCHCONTACTS
  • FIGURE 28. BIFOCAL INTRAOCULAR LENS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BIFOCAL INTRAOCULAR LENS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DIFFRACTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DIFFRACTIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CONCENTRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CONCENTRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY SECTORIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY SECTORIAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY HYDROPHILIC ACRYLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY HYDROPHILIC ACRYLIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY HYDROPHOBIC ACRYLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY HYDROPHOBIC ACRYLIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY SILICONE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CONTRAST SENSITIVITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CONTRAST SENSITIVITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DEPTH OF FOCUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DEPTH OF FOCUS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY HALOS & GLARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY HALOS & GLARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY PHACOEMULSIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY PHACOEMULSIFICATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE LENS EXCHANGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE LENS EXCHANGE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 58. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 59. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 60. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 62. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 76. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 78. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 89. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 90. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 101. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 102. CANADA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 103. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 104. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 113. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 115. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 116. MEXICO BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 117. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 118. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 121. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 122. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 123. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 124. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 125. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 126. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 127. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 129. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 130. BRAZIL BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 131. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 132. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 133. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 134. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 135. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 136. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 137. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 138. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 139. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 140. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 141. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 144. ARGENTINA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED KINGDOM BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 175. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 177. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 178. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 179. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 180. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 181. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 182. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 183. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 185. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 187. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 188. GERMANY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 189. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 191. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 192. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 193. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 194. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 195. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 196. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 197. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 198. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 199. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 201. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 202. FRANCE BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 203. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 205. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 206. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 207. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 208. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 209. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 210. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 211. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 213. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 215. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 216. RUSSIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 217. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 219. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 220. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 221. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 223. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 224. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 225. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 227. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 229. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 230. ITALY BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 231. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 233. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 234. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 235. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 237. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 238. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 239. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 240. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 241. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 243. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 244. SPAIN BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED ARAB EMIRATES BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 259. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 262. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 263. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 264. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 265. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 266. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 274. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 276. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 278. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 280. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 286. SOUTH AFRICA BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 287. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 289. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 290. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 291. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 292. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 293. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 294. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 295. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 296. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 297. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 299. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 300. DENMARK BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 303. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 304. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 305. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 306. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 307. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2018-2024 (USD MILLION)
  • TABLE 308. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL PERFORMANCE, 2025-2030 (USD MILLION)
  • TABLE 309. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 311. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 313. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 314. NETHERLANDS BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY CATARACT SURGERY, 2025-2030 (USD MILLION)
  • TABLE 315. QATAR BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. QATAR BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 317. QATAR BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2018-2024 (USD MILLION)
  • TABLE 318. QATAR BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY REFRACTIVE, 2025-2030 (USD MILLION)
  • TABLE 319. QATAR BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 320. QATAR BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 321. QATAR BIFOCAL INTRAOCULAR LENS MARKET SIZE, BY VISUAL